Predictors of high- versus low-intensity first-line multiple sclerosis treatments.

Chevalier AVG, Murray K, Lin A, Kerber K, Burke JF, Gyang TV

DOI: 10.1177/20552173261487868
Published: 2026 Jul-Sep
Container: Multiple sclerosis journal - experimental, translational and clinical
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20552173261487868,
  title = {Predictors of high- versus low-intensity first-line multiple sclerosis treatments.},
  author = {Chevalier AVG and Murray K and Lin A and Kerber K and Burke JF and Gyang TV},
  year = {2026},
  journal = {Multiple sclerosis journal - experimental, translational and clinical},
  doi = {10.1177/20552173261487868},
  url = {https://doi.org/10.1177/20552173261487868}
}

RIS

TY  - JOUR
TI  - Predictors of high- versus low-intensity first-line multiple sclerosis treatments.
AU  - Chevalier AVG
AU  - Murray K
AU  - Lin A
AU  - Kerber K
AU  - Burke JF
AU  - Gyang TV
PY  - 2026
JO  - Multiple sclerosis journal - experimental, translational and clinical
DO  - 10.1177/20552173261487868
UR  - https://doi.org/10.1177/20552173261487868
ER  -

APA

AVG, C., K, M., A, L., K, K., JF, B., & TV, G. (2026). Predictors of high- versus low-intensity first-line multiple sclerosis treatments.. Multiple sclerosis journal - experimental, translational and clinical. https://doi.org/10.1177/20552173261487868

Source records

pubmed · retrieved 2026-09-25T20:42:55.863Z